Lei Shi

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 5

Top Topics

Top Venues

Stem cells translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Zerui Wang, Tiantian Li, Ziying Zhang, Mengqi Yuan, Ming Shi, Fu-Sheng Wang, En-Qiang Linghu, Lei Shi
Human umbilical cord-derived mesenchymal stem cells for the treatment of decompensated cirrhosis (MSC-DLC-1): a dose-escalation, phase I trial protocol. BMJ open 13 (12) (2023)
Zerui Wang, Tiantian Li, Ziying Zhang, Mengqi Yuan, Ming Shi, Fu-Sheng Wang, En-Qiang Linghu, Lei Shi
Human umbilical cord-derived mesenchymal stem cells for the treatment of decompensated cirrhosis (MSC-DLC-1): a dose-escalation, phase I trial protocol. BMJ open 13 (12) (2023)
Zerui Wang, Tiantian Li, Ziying Zhang, Mengqi Yuan, Ming Shi, Fu-Sheng Wang, En-Qiang Linghu, Lei Shi
Human umbilical cord-derived mesenchymal stem cells for the treatment of decompensated cirrhosis (MSC-DLC-1): a dose-escalation, phase I trial protocol. BMJ open 13 (12) (2023)
Zerui Wang, Tiantian Li, Ziying Zhang, Mengqi Yuan, Ming Shi, Fu-Sheng Wang, En-Qiang Linghu, Lei Shi
Human umbilical cord-derived mesenchymal stem cells for the treatment of decompensated cirrhosis (MSC-DLC-1): a dose-escalation, phase I trial protocol. BMJ open 13 (12) (2023)
Tian-Tian Li, Ze-Rui Wang, Wei-Qi Yao, En-Qiang Linghu, Fu-Sheng Wang, Lei Shi
Stem Cell Therapies for Chronic Liver Diseases: Progress and Challenges. Stem cells translational medicine 11 (9) (2022)